ReviewFrontiers in surgery2026
Advancing precision triage in strangulated small bowel obstruction: from static scores to dynamic multiparametric models.
Review in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strangulated small bowel obstruction (SSBO) is a life-threatening surgical emergency. Current clinical assessment, which predominantly relies on static and isolated parameters, often fails to accurately identify the critical transition from reversible ischemia to irreversible bowel necrosis. This diagnostic gap often results in delayed recognition and suboptimal timing of surgical intervention. Consequently, early and accurate risk stratification is imperative to guide clinical decision-making. The field is currently shifting from static evaluations toward dynamic, continuous predictive models. This narrative review examines the paradigm shift in SSBO risk assessment-from static, single-timepoint tools to integrated, intelligent systems capable of analyzing temporal data, while critically examining their current limitations in clinical validation and real-world applicability. We evaluate the characteristics and clinical applicability of various risk-stratification instruments, with a focused discussion on the role of artificial intelligence (AI) and machine learning (ML) in processing multimodal time-series data. Ultimately, we aim to outline a framework for standardized risk stratification to enhance triage precision and to advance SSBO management from a predominantly experience-based practice toward a standardized, evidence-based approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.